Chlamydia inhibits interferon γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1931-1937

  Zhong, Guangming ^a   Fan, Tao ^a   Liu, Li ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chlamydia upstream stimulatory factor 1; Interferon induction; Major histocompatibility complex class II; Protein degradation

Indexed keywords

GAMMA INTERFERON;

ANTIGEN EXPRESSION; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

CELL LINE; CHLAMYDIA INFECTIONS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; NUCLEAR PROTEINS; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UPSTREAM STIMULATORY FACTORS;

EID: 0033591635     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1931     Document Type: Article

References (49)

1. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
2. Ploegh, H.L. 1998. Viral strategies of immune evasion. Science. 280:248-253.
3. Ahn, K., A. Gruhler, B. Galocha, T.R. Jones, E.J. Wiertz, H.L. Ploegh, P.A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:613-621.
4. Hengel, H., T. Flohr, G.J. Hammerling, U.H. Koszinowski, and F. Momburg. 1996. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:2287-2296.
5. Lehner, P.J., J.T. Karttunen, G.W. Wilkinson, and P. Cresswell. 1997. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA. 94: 6904-6909.
6. Jones, T.R., and L. Sun. 1997. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970-2979.
7. Jones, T.R., E.J. Wiertz, L. Sun, K.N. Fish, J.A. Nelson, and H.L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA. 93: 11327-11333.
8. Machold, R.P., E.J. Wiertz, T.R. Jones, and H.L. Ploegh. 1997. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185:363-366.
9. Schust, D.J., D. Tortorella, J. Seebach, C. Phan, and H.L. Ploegh. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188:497-503.
10. Wiertz, E.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:769-779.
11. Hughes, E.A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA. 94:1896-1901.
12. Collins, K.L., B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 391:397-401.
13. Reiner, N.E., W. Ng, T. Ma, and W.R. McMaster. 1988. Kinetics of gamma interferon binding and induction of major histocompatibility complex class 11 mRNA in Leishmania-infected macrophages. Proc. Natl. Acad. Sci. USA. 85:4330-4334.
14. Schuller, S., S. Kugler, and W. Goebel. 1998. Suppression of major histocompatibility complex class I and class II gene expression in Listeria monocytogenes-infected murine macrophages. FEMS Immunol. Med. Microbiol. 20:289-299.
15. Vachiery, N., I. Trap, P. Totte, D. Martinez, and A. Bensaid. 1998. Inhibition of MHC class I and class II cell surface expression on bovine endothelial cells upon infection with Cowdria ruminantium. Vet. Immunol. Immunopathol. 61:37-48.
16. Heise, M.T., M. Connick, and H.W.T. Virgin. 1998. Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1037-1046.
17. Heise, M.T., J.L. Pollock, A. O'Guin, M.L. Barkon, S. Bormley, and H.W.T. Virgin. 1998. Murine cytomegalovirus infection inhibits IFN-γ-induced MHC class II expression on macrophages: the role of type I interferon. Virology. 241:331-344.
18. Miller, D.M., B.M, Rahill, J.M. Boss, M.D. Lairmore, J.E. Durbin, J.W. Waldman, and D.D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
19. Moulder, J.W. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190.
20. Grayston, J.T., C.C. Kuo, L.A. Campbell, S.P. Wang, and L.A. Jackson. 1997. Chlamydia pneumoniae and cardiovascular disease. Cardiologia. 42:1145-1151.
21. Grayston, J.T., and S. Wang. 1975. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132:87-105.
22. Beatty, W.L., R.P. Morrison, and G.I. Byrne. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
23. Holland, M.J., R.L. Bailey, D.J. Conway, F. Culley, G. Miranpuri, G.I. Byrne, H.C. Whittle, and D.C. Mabey. 1996. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin. Exp. Immunol. 105:429-435.
24. Fan, T., H. Lu, H. Hu, L. Shi, G.A. McClarty, D.M. Nance, A.H. Greenberg, and G. Zhong. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187: 487-496.
25. Geginat, G., M. Lalic, M. Kretschmar, W. Goebel, H. Hof, D. Palm, and A. Bubert. 1998. Th1 cells specific for a secreted protein of Listeria monocytogenes are protective in vivo. J. Immunol. 160:6046-6055.
26. Perry, L.L., K. Feilzer, and H.D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways. J. Immunol. 158:3344-3352.
27. Arunachalam, B., M. Pan, and P. Cresswell. 1998. Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules. J. Immunol. 160:5797-5806.
28. Chang, C.H., J.D. Fontes, M. Peterlin, and R.A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.
29. Albanesi, C., A. Cavani, and G. Girolomoni. 1998. Interferon-γ-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J. Invest. Dermatol. 110:138-142.
30. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
31. Muhlethaler-Mottet, A., L.A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO (Eur. Mol. Biol. Organ.) J. 16:2851-2860.
32. Muhlethaler-Mottet, A., W. Di Berardino, L.A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:157-166.
33. Walter, M.J., D.C. Look, R.M. Tidwell, W.T. Roswit, and M.J. Holtzman. 1997. Targeted inhibition of interferon-γ-dependent intercellular adhesion molecule-1 (ICAM-1) expression using dominant-negative Statl. J. Biol. Chem. 272: 28582-28589.
34. Chon, S.Y., H.H. Hassanain, R. Pine, and S.L. Gupta. 1995. Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene. J. Interferon Cytokine Res. 15:517-526.
35. Barbour, A.G., K. Amano, T. Hackstadt, L. Perry, and H.D. Caldwell. 1982. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J. Bacteriol. 151: 420-428.
36. + T cells in adoptive immunity to Listeria monocytogenes in the liver. Immunology. 82:249-254.
37. Kaufmann, S.H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
38. Su, H., R. Messer, W. Whitmire, E. Fischer, J.C. Portis, and H.D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 188:809-818.
39. Sedmak, D.D., S. Chaiwiriyakul, D.A. Knight, and W.J. Waldmann. 1995. The role of interferon β in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells. Arch. Virol. 140:111-126.
40. Rodel, J., A. Groh, H. Vogelsang, M. Lehmann, M. Hartmann, and E. Straube. 1998. Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. Infect. Immun. 66:4491-4495.
41. Wang, D. and S.H. Sul. 1997. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J. Biol. Chem. 272: 26367-26374.
42. Aperlo, C., E.K. Boulukos, and P. Pognonec. 1996. The basic region/helix-loop-helix/leucine repeat transcription factor USF interferes with Ras transformation. Eur. J. Biochem. 241:249-253.
43. Reisman, D. and V. Rotter. 1993. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 21:345-350.
44. Lupas, A., J.M. Flanagan, T. Tamura, and W. Baumeister. 1997. Self-compartmentalizing proteases. Trends Biochem. Sci. 22:399-404.
45. Glas, R., M. Bogyo, J.S. McMaster, M. Gaczynska, and H.L. Ploegh. 1998. A proteolytic system that compensates for loss of proteasome function. Nature. 392:618-622.
46. Gottesman, S., M.R. Maurizi, and S. Wickner. 1997. Regulatory subunits of energy-dependent proteases. Cell. 91: 435-438.
47. Ploegh, H.L. 1997. Destruction of proteins as a creative force. Immunol. Today. 18:269-271.
48. Bogyo, M., S. Shin, J.S. McMaster, and H.L. Ploegh. 1998. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5:307-320.
49. Groll, M., L. Ditzel, J. Lowe, D. Stock, M. Bochtler, H.D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 386:463-471.